InsidersTradesSigma
Follow the 安图生物 share price and the full insider trade history of the company, a listed issuer based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 安图生物 has logged 2 reports. Market capitalisation: €18.7bn. The latest transaction was reported on 4 July 2024 (Purchase). Among the most active insiders: 苗拥军. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
安图生物是一家专注于健康和制药领域的公司，提供诊断解决方案和生物制药产品。该公司在XSHG市场上市。